Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005294440 | SCV005954833 | likely pathogenic | Inborn genetic diseases | 2024-12-23 | criteria provided, single submitter | clinical testing | The c.2468G>A (p.C823Y) alteration is located in exon 4 (coding exon 4) of the TET3 gene. This alteration results from a G to A substitution at nucleotide position 2468, causing the cysteine (C) at amino acid position 823 to be replaced by a tyrosine (Y). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. This missense alteration is located in a region that has a low rate of benign missense variation (Lek, 2016; Firth, 2009). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic. |